Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Metformin for cancer prevention.

Literature DB >> 21695613

Metformin for cancer prevention.

Yonghua Yang.

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 2011 PMID： 21695613 DOI： 10.1007/s11684-011-0112-3

Source DB: PubMed Journal: Front Med ISSN： 2095-0217 Impact factor: 4.592

× No keyword cloud information.

15 in total

1. Metformin suppresses intestinal polyp growth in ApcMin/+ mice.

Authors: Ayako Tomimoto; Hiroki Endo; Michiko Sugiyama; Toshio Fujisawa; Kunihiro Hosono; Hirokazu Takahashi; Noriko Nakajima; Yoji Nagashima; Koichiro Wada; Hitoshi Nakagama; Atsushi Nakajima
Journal: Cancer Sci Date: 2008-09-18 Impact factor: 6.716

2. Metformin suppresses colorectal aberrant crypt foci in a short-term clinical trial.

Authors: Kunihiro Hosono; Hiroki Endo; Hirokazu Takahashi; Michiko Sugiyama; Eiji Sakai; Takashi Uchiyama; Kaori Suzuki; Hiroshi Iida; Yasunari Sakamoto; Kyoko Yoneda; Tomoko Koide; Chikako Tokoro; Yasunobu Abe; Masahiko Inamori; Hitoshi Nakagama; Atsushi Nakajima
Journal: Cancer Prev Res (Phila) Date: 2010-09-01

3. Metformin reduces cisplatin-mediated apoptotic death of cancer cells through AMPK-independent activation of Akt.

Authors: Kristina Janjetovic; Ljubica Vucicevic; Maja Misirkic; Urosh Vilimanovich; Gordana Tovilovic; Nevena Zogovic; Zoran Nikolic; Svetlana Jovanovic; Vladimir Bumbasirevic; Vladimir Trajkovic; Ljubica Harhaji-Trajkovic
Journal: Eur J Pharmacol Date: 2010-11-27 Impact factor: 4.432

Review 4. Improving survival with metformin: the evidence base today.

Authors: J H B Scarpello
Journal: Diabetes Metab Date: 2003-09 Impact factor: 6.041

5. The influence of glucose-lowering therapies on cancer risk in type 2 diabetes.

Authors: C J Currie; C D Poole; E A M Gale
Journal: Diabetologia Date: 2009-07-02 Impact factor: 10.122

6. Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells.

Authors: Ryan J O Dowling; Mahvash Zakikhani; I George Fantus; Michael Pollak; Nahum Sonenberg
Journal: Cancer Res Date: 2007-11-15 Impact factor: 12.701

7. The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level.

Authors: I Ben Sahra; K Laurent; A Loubat; S Giorgetti-Peraldi; P Colosetti; P Auberger; J F Tanti; Y Le Marchand-Brustel; F Bost
Journal: Oncogene Date: 2008-01-21 Impact factor: 9.867

8. Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission.

Authors: Heather A Hirsch; Dimitrios Iliopoulos; Philip N Tsichlis; Kevin Struhl
Journal: Cancer Res Date: 2009-09-14 Impact factor: 12.701

9. Antidiabetic therapies affect risk of pancreatic cancer.

Authors: Donghui Li; Sai-Ching J Yeung; Manal M Hassan; Marina Konopleva; James L Abbruzzese
Journal: Gastroenterology Date: 2009-04-16 Impact factor: 22.682

10. The effects of adiponectin and metformin on prostate and colon neoplasia involve activation of AMP-activated protein kinase.

Authors: Mahvash Zakikhani; Ryan J O Dowling; Nahum Sonenberg; Michael N Pollak
Journal: Cancer Prev Res (Phila) Date: 2008-10

6 in total

Metformin for cancer prevention.

1. Metformin suppresses intestinal polyp growth in ApcMin/+ mice.

2. Metformin suppresses colorectal aberrant crypt foci in a short-term clinical trial.

3. Metformin reduces cisplatin-mediated apoptotic death of cancer cells through AMPK-independent activation of Akt.

Review 4. Improving survival with metformin: the evidence base today.

5. The influence of glucose-lowering therapies on cancer risk in type 2 diabetes.

6. Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells.

7. The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level.

8. Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission.

9. Antidiabetic therapies affect risk of pancreatic cancer.

10. The effects of adiponectin and metformin on prostate and colon neoplasia involve activation of AMP-activated protein kinase.

1. Leucine signaling in the pathogenesis of type 2 diabetes and obesity.

Review 2. Oncogene-directed alterations in cancer cell metabolism.

3. Improving galegine production in transformed hairy roots of Galega officinalis L. via elicitation.

4. Dietary intervention in acne: Attenuation of increased mTORC1 signaling promoted by Western diet.

Review 5. Targeting AMPK for cancer prevention and treatment.

Review 6. Nutritional Modulation of AMPK-Impact upon Metabolic-Inflammation.